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1. INTRODUCTION
Tuberculosis (TB), a chronic infectious disease, is a major public 
health concern that accounted for 10 million new cases and 1.2 mil-
lion deaths globally in 2018 [1], and was among the top 10 causes 
of death [2]. Different preventive measures along with Directly 
Observed Treatment Short-course (DOTS) have been used glob-
ally to reduce the prevalence of TB that resulted in the reduction of 
TB incidence by 1.6% annually between the years 2000 and 2018. 
The sustainable development goals, adopted by the United Nations 
aspire to end the TB epidemic by 2030 [2].
The major social determinants of TB include food insecurity and 
malnutrition, poor housing and environmental conditions, as 
well as financial, geographic and cultural barriers to health care 
access [3]. The incidence of TB has been falling more quickly in 
countries with high human development index, low child mor-
tality and denizens with better access to improved sanitation [4]. 
Consequently, higher incidences of TB were less likely countries 
with higher per-capita income and higher health expenditure com-
pared to other countries [4]. At the household level, TB was mostly 
associated with smoking, alcohol consumption, low body mass 
index, lower level of personal education, unemployment, and lower 
household wealth [5]. Therefore, higher incidences of TB are likely 
in societies with high economic inequalities among families with 
low Socioeconomic Status (SES), and where people suffer from 
food insecurity and malnutrition.
Almost half of the world’s TB burden is in the South-East Asian 
region, and Bangladesh ranked fifth among the highest TB burden 
countries in this region [6]. In 2015, the incidence and mortality 
rate of TB in Bangladesh was 225 and 45 per 100,000 population, 
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A B S T R AC T
To eliminate TB from the country by the year 2030, the Bangladesh National Tuberculosis (TB) Program is providing free 
treatment to the TB patients since 1993. However, the patients are still to make Out-of-their Pocket (OOP) payment, particularly 
before their enrollment Directly Observed Treatment Short-course (DOTS). This places a significant economic burden on poor-
households. We, therefore, aimed to estimate the Catastrophic Health Expenditure (CHE) due to TB as well as understand 
associated difficulties faced by the families when a productive family member age (15–55) suffers from TB. The majority of the 
OOP expenditures occur before enrolling in. We conducted a cross-sectional study using multistage sampling in the areas of 
Bangladesh where Building Resources Across Communities (BRAC) provided TB treatment during June 2016. In total, 900 new 
TB patients, aged 15–55 years, were randomly selected from a list collected from BRAC program. CHE was defined as the OOP 
payments that exceeded 10% of total consumption expenditure of the family and 40% of total non-food expenditure/capacity-to-
pay. Regular and Bayesian simulation techniques with 10,000 replications of re-sampling with replacement were used to examine 
robustness of the study findings. We also used linear regression and logit model to identify the drivers of OOP payments and 
CHE, respectively. The average total cost-of-illness per patient was 124 US$, of which 68% was indirect cost. The average CHE 
was 4.3% of the total consumption and 3.1% of non-food expenditure among the surveyed households. The poorest quintile of 
the households experienced higher CHE than their richest counterpart, 5% vs. 1%. Multiple regression model showed that the 
risk of CHE increased among male patients with smear-negative TB and delayed enrolling in the DOTS. Findings suggested that 
specific groups are more vulnerable to CHE who needs to be brought under innovative safety-net schemes.
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This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
*Corresponding author. Email: mahfuzar_r@yahoo.com 
Data availability statement: Interested researcher may contact the corresponding author 
[MR] for data and study materials.
In Press, Corrected Proof
2 A.S. Chowdhury et al. / Journal of Epidemiology and Global Health. In Press
respectively [1]. The major consequences of TB include drug resis-
tance with higher morbidity and deaths, and significant impact on 
the economic development since the diseases generally affects the 
most economically productive age group of the population [7–12]. 
In Bangladesh, the TB eradication interventions are mostly funded 
by the international donors that demand quick case detection and 
successful treatment to stop TB before these funds support are 
exhausted [6].
Since 1993, the National TB Control Program (NTP) of the 
Government of Bangladesh (GoB), has been offering free treat-
ment to TB patients under the popularly known DOTS program 
as recommended by the World Health Organization (WHO). This 
package includes direct diagnostic tests and medication costs but 
not the other associated costs. These indirect expense along with 
lost income is an increasing concern in the control of TB [13]. 
Patients and their households incur direct, “Out-of-Pocket (OOP)” 
expenses, i.e. health payments borne by the patients and their 
households while receiving health services. This includes expenses 
for transport, hospitalization, other medicines, and additional 
food costs [14]. OOP spending is the major component of health 
care payment in most low- and middle-income countries [15–17]. 
Globally, around 150 million people experience Catastrophic 
Health Expenditure (CHE) while around 100 million are forced 
into poverty consequent to OOP [18]. In the case of TB, expenses 
are generally observed to be higher before the commencement of 
DOTS, which is also likely in Bangladesh context [19,20]. These 
expenses turn out to be catastrophic for the socially and economi-
cally marginalized population who are more likely to have TB than 
the rest of the population [21–24]. Tanimura et al. [16] reported 
that the total cost of TB treatment involved was over a-half (58%) of 
the individual income and 39% of the household income. We thus 
strongly suspected that in Bangladeshi households with one or more 
TB patients might have faced CHE due to their OOP direct medical 
and/or non-medical costs. Abolhallaje et al. [25] have found CHE 
to be closely associated with demographic and economic character-
istics of the households, e.g. age, sex, employment status of house-
hold heads, dependency ratio at household and the status of health 
insurance [6]. Notably, CHE was faced by households expending 
more than 10% of their consumption expenditure/income or 40% 
of their non-food consumption. The findings suggest that even 
minor illness expenditures may lead to financial erosion among 
the poor-households [9]. CHE reflects the economic burden and 
barriers that negatively influence access to TB care by individuals. 
Consequently, in the health system financing, the WHO and others, 
such as STOP TB movement emphasize on reducing ‘catastrophic 
costs’, because of its serious implications such as impoverishment, 
delay in seeking treatment and/or its discontinuation of TB treat-
ment and emergence of multidrug- resistant TB [26]. Failure or 
delay in seeking TB treatment additionally favors increasing trans-
mission to others. Therefore, equity and universal healthcare for 
TB patients and preventing CHE of their households have long 
been identified as crucial by the health policymakers [2,3]. The 
current WHO have also included prevention/reduction of CHE as 
one of their strategies to stop TB [14,27,28].
It is thus essential for the policymakers to innovate and/or adopt 
context-specific measures to reduce the incidence of CHE during 
illness episodes. In devising measures to reduce CHE, the first log-
ical step would be to assess the prevailing situation and identify the 
major drivers of cost and consequent CHE. There is a serious lack 
of information on the incidence of catastrophic cost of TB patients 
and its determinants in Bangladesh to inform the policymakers. 
This is why we conducted the current study to estimate the cost-
of-illness of TB and the incidence of CHE, and also identify their 
determinants.
2. MATERIALS AND METHODS
2.1. Study Settings
The Building Resources Across Communities (BRAC) Bangladesh, 
a Dhaka-based international non-government organization 
(NGO), is implementing the NTP in partnership with the GoB, in 
298 sub-districts under 42 districts and additional seven city corpo-
rations serving a total of 92.9 million people. BRAC Health Centers 
(BHCs) in various parts of the country are equipped with the nec-
essary human resources and logistics for the TB control program. 
BRAC’s Shasthya Shebikas (frontline community health volunteers, 
SSs) are the first line health workers for TB screening and deliver-
ing DOTS in the rural communities. SSs initiate DOT under the 
guidance of the BRAC program organizers or para- professionals. 
The study was conducted in BRAC TB areas with TB patients who 
were enrolled in DOTS.
2.2. Study Design and Sampling
This was a cross-sectional study to assess the TB treatment costs and 
the incidence of CHE from the onset of TB illness to its diagnosis 
and through to the DOT treatment period. A multistage sampling 
technique (from district to sub-district) was adopted for selecting 
30 sub-districts, using the probability proportional to size method. 
The sample size was determined based on the maximum proportion 
(0.5) with a 5% significance level, and with a 5% precision. Thus, 
the minimum calculated sample size was 400. To reduce the design 
effect (2) and keep provision for non-response (100 households), we 
needed a total of 900 samples (400 × 2 + 100 = 900) for this study. 
The sample enrolled in each cluster/sub-district was 900/30 = 30. The 
study participants were identified by systemic random sampling from 
the TB patients enrolled in BRAC DOTS centers between January 
and April 2016. Only newly diagnosed TB patients, aged 15–55 years, 
completing a minimum of 1 and a maximum of 6 months treatment 
were included. Extrapulmonary TB patients, previously treated TB 
patients, multi-drug-resistant tuberculosis (MDR-TB) patients, and 
patients who discontinued treatment or had a fatal outcome were 
excluded. We excluded them because such patients take longer time 
to diagnose as well as their treatments are also different and more 
complex, and consequently their overall, as well as component costs, 
would also be different than pulmonary TB.
Applying systematic random sampling and defining inclusion 
and exclusion criteria, we prepared a list of eligible patients from 
the BRAC TB Program records maintained at each sub-district. 
Eventually, we identified 1780 eligible patients – there were 60 eligi-
ble patients, on average, at each of the 30 study sub-districts and we 
thus selected every second patient in our study sample. Consequent 
to non-response and missing households, we ended up having a 
total of 866 households.
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2.3. Data Collection
In a review of existing literature, we developed a structured ques-
tionnaire in the local language, Bangla, for our field survey, and sent 
it to the experts of these fields for their feedbacks. We prepared a 
revised version adjusting for their suggestions/advice and pretested 
that on a few patients. The questionnaire was then submitted to the 
ethical review committee for their approval. We recruited research 
assistants and enumerators (master degree holders) and trained 
them for 5 days for data collection that included mock interviews, 
one-on-one and group discussions, field exposure, and testing. The 
interviews were conducted at respective homes of the patients in 
Bangla. A detailed list of demographic variables, service utilization, 
pre-diagnostic costs, direct and indirect expenses, household food 
and non-food expenses, earnings, income, assets, and lost income 
of patients and caregivers information was collected. To accomplish 
the field survey our enumerators visited every selected household, 
and those not found after several visits within a given period of 
time were recorded as missing sample.
The interview team was supervised and monitored by trained 
supervisors during data collection, and the researchers stayed most 
of the time in the field to oversee the data collection process as well 
as to ensure data quality by resurveying few households. Costs data 
were validated throughout the interview by repeated questioning 
and spot-checking.
2.4. Outcome Data Assessments
Information on treatment costs was determined for the newly diag-
nosed pulmonary TB patients. All costs were calculated from the 
moment of onset of symptoms up to the field survey that included 
diagnosis and treatment costs, and all direct and indirect costs in 
both the pre-treatment and treatment periods. Direct patient cost 
included all OOP expenditures of patients concerning TB. Table 1 
describes the different cost heads, e.g. medical costs were classi-
fied as doctors consultation fees1, diagnostic costs2 related to TB 
infection, medicine costs3 other than DOTS (if required); and for 
in- patients the hospital admission fees, bed charge for an over-
night stay in hospital, and treatment. Food and travel costs of both 
patients and caregivers, when involved, were classified as direct 
Table 1 | Cost classifications and their indicators
Heads 
of cost Sub-head Indicators Time span
Direct Medical 
cost
Doctor’s consultation fees, 
diagnostic test costs, medicine 
costs (other than DOTS, if any), 














Food and travel costs during TB 
episode for both patients and 
caregivers.
Indirect Loss of 
income/
wage
Income loss due to TB infections 
for both patients and caregivers.
non-medical costs (Table 1). Indirect patient costs included the 
cost of work absenteeism and loss of wages due to the inability to 
work because of the illness (Table 1). To assess the degree of income 
loss, the number of absent days was multiplied by the estimated 
daily income of the patients and their caregivers.
The primary outcome variable for this study was the CHE, which 
has no single accepted definition. Some studies assessed payments 
made in relation to the budget share [29], while others argued that 
the catastrophic cost needs to be measured in relation to the capac-
ity to pay (i.e. household net expenditure of food). Nonetheless, 
all agree that often households spend a large proportion of their 
budget on health care, at the expense of other goods and services 
that negatively impacts their living standards. Often, the choice of 
the threshold is arbitrary but two commonly used ones are 10% of 
total income or 40% of non-food income [29]; the average annual 
household income is 2305 US$4 and consumption expenditure 
including food (47.70%) and non-food (52.30%) is 2272 US$ in 
Bangladesh [30]. From our survey, we found that the per-capita 
annual income was 441.05 US$ and per-capita annual food and 
non-food expenditures were 245.88 and 167.67 US$, respectively 
for our study patients (Supplementary Table 1).
2.5. Data Analysis
The direct TB treatment costs to a household were calculated by 
adding all direct medical and non-medical costs both before enroll-
ing in DOTS centers and during the DOTS treatment. Indirect 
costs were estimated using friction method in which the difference 
between the income before TB infection of the patients and after 
TB infection of patients and caregivers is estimated as productivity 
loss due to TB [31]. For this study, we considered indirect costs as 
the income loss of the patients and their caregivers due to TB infec-
tion during the entire episode starting from the beginning of symp-
tom that illustrates productivity loss. The total cost-of-illness was 
obtained by summing all direct and indirect costs. All the monetary 
values were collected in local currency (Taka or BDT) and then trans-
formed into US$ value using the current exchange rate (1 US$ = 83 
BDT). Descriptive statistics focusing on frequency distribution, aver-
age illness cost, and their standard deviation were analyzed to report 
demographic characteristics, distribution of illness cost according 
to different socioeconomic characteristics of the TB patients as well 
as their affected households. We adopted two most commonly used 
measures to estimate the incidence of CHE among the TB patients 
and their affected households: OOP payments greater than 10% of 
the household annual income, and OOP payments greater than 40% 
of household non-food expenditure [14,29]. To check the robustness 
of the CHE estimation, regular and Bayesian simulations with 10,000 
re-sampling with replacements were used.
A linear and a logistic regression model were used to predict the 
determinants of direct, indirect cost, and CHE. The models were 
as follows:
     ln E x ui
i
n





    CHEi
i
n





1The amount paid to the doctors from the onset of symptoms till the interview date.
2All the diagnostic costs related to TB from the onset of symptoms till the interview date.
3The total cost of medicines from the onset of symptoms till the interview date. 41 US$ = 83 BDT.
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Consultation fees 3.07 5.47 2.50
Diagnostic cost 15.15 33.22 12.10
Medicine 15.33 25.98 12.30
Admission fees 0.03 0.35 0.00
Bed charges 0.17 2.43 0.10
Food cost 1.35 4.07 1.10
Travel cost 3.26 5.83 2.60
Attendant cost 2.73 7.18 2.20
Total direct cost (sub-total) 41.10 67.23 32.90
Indirect cost of patient 76.21 153.51 61.10
Indirect cost of attendant 7.51 32.51 6.00
Total indirect cost (sub-total) 83.73 155.04 67.10
Total cost per patient 124.82 179.63 −
Number of observations, n = 866.
Equation (1) represents the linear regression model where Ln (E) is 
the natural logarithm of household expenditure due to TB, b0 is the 
constant term and bi is the coefficients of explanatory variables to 
be estimated. Equation (2) represents the logistic regression model 
in which CHE is the binary variable stands CHE; CHE takes the value 
of 1 if the expenditure is catastrophic for the household else a 0. 
The explanatory variables included demographic and socioeco-
nomic characteristics of the households, health-seeking behaviors 
of the patients, and types of TB. The odds ratios were calculated for 
the logistic regression to examine the constant effect of the predic-
tor on the likelihood of CHE to occur. The Principal Component 
Analysis (PCA) was applied for constructing the asset quintiles.
3. RESULTS
3.1. Cost-of-Illness
The cost-of-illness was categorized under direct and indirect costs. 
Table 2 reports the average costs (by category) per patient during 
the TB infection. The total cost per patient was 124.8 US$ in which 
the largest proportion (67%) was due to income loss of the patients 
and their caregivers. The patients’ income loss was 61% of the total 
cost-of-illness. Among various components of the direct costs, a 
major proportion was made up of TB diagnostic and medicine cost 
together they constitute 24% of the total cost-of-illness (Table 2). 
The TB patients additionally spent a significant amount of money 
on food and travel during the TB episodes.
3.2.  Distribution of Cost-of-Illness based on 
Socioeconomic Profile of TB Patients
The average cost-of-illness, based on demographic and socioeco-
nomic features of the TB patients and their households, have been 
presented in Table 3. Among the study participating TB patients, 
54% were males with an average total cost-of-illness of 173 US$, 
which was much higher than their female counterparts (Table 3). 
Among the four age groups, the total cost-of-illness was high-
est among the 25–35 years age group (154 US$) who constituted 
23% of the total sample. This higher cost can be explained by the 
higher indirect costs; the average income loss of this age group was 
107 US$ during the TB episode. The average expense of patients 
without formal education reported was 123 US$, and that for those 
tertiary level of education was higher than the other groups. Thus, 
the cost-of-illness also related to the level of education and this was 
explained by their higher indirect costs.
The cost-of-illness also varied depending on the patient’s occupa-
tion. In our sample, 15% and 17% of the patients were employed in 
agricultural and non-agricultural labor, respectively. The average 
expense of non-agricultural laborers was 186 US$ and that for agri-
cultural laborers was 118 US$ during their TB episode. Patients in 
services spent the highest amount of 193 US$ during their TB epi-
sode. Housewives, the largest group in our sample (37%), spent the 
lowest amount of 64 US$, and their indirect costs were much lower 
than other occupational groups. We divided the households into 
five asset quintiles by wealth index, which placed the households 
into a continuous scale of relative wealth reflecting their cumulative 
living standards (Table 3). The households of the TB patients were 
equally distributed (20%) among the five quintiles starting from 
the poorest to the richest, and their total average treatment costs 
are shown in Table 3. The total average cost per patient increased 
with wealth quintiles - the richest quintiles spent over 200 US$ 
during their TB episodes, while those in the lowest quintile spent 
128 US$; the cost for the patients in the second through the fourth 
quintiles gradually increased from 136 to 198 US$ (Table 3).
Table 3 shows that the average total cost-of-illness highly discrep-
ant among different groups which resulted from mainly variation 
in indirect costs. The variations in direct costs depended on the 
type of service providers. The richest group mostly preferred pri-
vate service providers, e.g. private hospitals and clinics. Conversely, 
the poorest group mostly sought care from government or NGO 
operated hospitals, which were cheaper than the private hospitals 
and clinics. Table 3 shows that the richest and the poorest quintiles 
spent 54 and 33 US$, respectively as the direct cost-of-illness.
3.3.  Incidence of Catastrophic  
Health Expenditure
As mentioned earlier, we considered two different definitions of 
estimating CHE, i.e. health expenditure exceeding 10% of total 
consumption expenditure (or income) and 40% of total non-food 
consumption. We noted that the incidence of catastrophic cost was 
4.3% vs. 3.1% using these two definitions respectively with their 
confidence intervals of 3–6% and 2–4%, respectively (Table 4).
To examine the robustness of our findings, we used statistical 
simulation methods, i.e. regular simulation and Bayesian sim-
ulation with 10,000 replication of resampling with replace-
ment. The regular and Bayesian simulation are shown in 
Supplementary Tables 2 and 3, respectively which produced a 
similar mean value and confidence intervals with the original 
findings (Table 4). In the Bayesian technique, a prior distribu-
tion was used along with data to provide a posterior distribu-
tion, using a binary prior in the analysis. From 10,000 Markov 
Chain Monte Carlo, we observed similar results with a very small 
variation in the cardinal confidence interval (Supplementary 
Table 3). Supplementary Figure 1 describes the diagnostic test 
of Bayesian estimation. The trace plots demonstrated that the 
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Table 3 | Socioeconomic background of TB patients and average cost of illness
Characteristic N = 866 (%) Average direct  cost-of-illness (US$)
Average indirect 
cost-of-illness (US$)
Average total  
cost-of-illness (US$)
Sex
Male 465 53.7 42.23 130.53 172.76
Female 401 46.3 39.79 29.45 69.24
Age group
15–25 195 22.5 43.61 56.09 99.70
25–35 198 22.9 46.18 107.32 153.50
35–45 212 24.5 41.04 89.80 130.84
>45 261 30.1 35.41 81.55 116.96
Marital status
 Married 680 78.5 40.31 87.24 127.56
 Unmarried 105 12.1 47.96 86.12 134.08
 Others (divorced, widowed) 81 9.40 38.79 51.11 89.90
Education
 No formal education 376 43.4 35.30 87.60 122.90
 Primary 243 28.1 38.87 86.26 125.13
 Secondary 232 26.8 51.14 70.49 121.63
 Tertiary 15 1.7 67.37 150.34 217.71
Occupation
 Agriculture labor 126 14.6 32.51 85.59 118.10
 Non-farm labor 96 11.09 30.78 139.47 170.25
 Transport worker 49 5.66 51.86 164.22 216.08
 Service (Salaried job) 67 7.7 68.35 125.08 193.43
 Business 108 12.5 33.20 154.69 187.89
 Unemployed 37 4.3 71.11 112.30 183.41
 Housewife 316 36.5 37.52 26.16 63.68
 Student 35 4 55.61 2.45 58.06
 Other 32 3.7 43.74 84.17 127.90
Asset quintiles
 Poorest 174 20.1 32.89 95.24 128.13
 Second 176 20.3 33.34 102.19 135.53
 Third 173 20 37.18 121.30 158.48
 Fourth 174 20.1 48.60 148.98 197.58
 Richest 169 19.5 53.90 157.58 211.48
Table 4 | Incidence of CHE
Threshold level Obs. Mean SD [95% confidence interval]
10% of total consumption 
expenditure
866 0.043 0.202 0.029 0.056
40% of total non-food 
expenditure
866 0.031 0.174 0.019 0.043
(using both thresholds) compared to other occupations that varied 
between 2% and 4% (Supplementary Table 4). Smear-negative 
patients experienced a higher proportion of CHE incidences than 
smear-positive ones (7% and 6.5% vs. 3.4% and 2.1% under 10% 
and 40% thresholds, respectively), likely due to the involvement of 
the need for greater and more complex diagnostic procedures at 
higher costs. Most of these patients sought the services of different 
health care systems for multiple lab tests before being diagnosed 
with TB (Supplementary Table 4).
3.5. Determinants of Cost-of-Illness and CHE
The results of linear and logistic regression models can be found 
in Supplementary Table 5. The outcome variables in our linear 
regression models were: total cost-of-illness per patient, and direct 
and indirect costs related to TB patients and their caregivers, and 
the distribution of the outcome variables were normalized using 
natural logarithm. For the logistic regression model, the outcome 
variables (CHE) took value 1 for household facing CHE and 0 
otherwise. Corresponding odds ratios are presented in Supplementary 
Table 5. Demographic and socioeconomic characteristics of the TB 
patients and their households constituted the covariates.
mean values were convergent at a single point, autocorrelation 
was almost zero, the mean values were normally distributed, and 
the prior distribution overlapped with the posterior distribution 
providing strong support to our original findings.
3.4.  Incidence CHE by Socioeconomic 
Characteristics
We observed that the incidence of CHE varied by sex (Supplementary 
Table 4). Males had a higher chance of experiencing CHE than the 
females (4.5% for men vs. 4% for women under the 10% thresh-
old; and 4% for men vs. 2.5% for women under the 40% thresh-
old). Incidence among the unemployed was the highest at 8% 
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Models 1–3, presented in Supplementary Table 5, describe the esti-
mated coefficients for the linear regression model, which suggest a 
close relation of cost-of-illness with and SES of the patients. Male 
patients are more cost-sensitive than female patients, the coeffi-
cients for males in models 1 and 3 were positive and significantly 
different from zero implying that they incur more indirect costs 
than the females increasing their total cost-of-illness. The level of 
education of the patients also influenced the cost-of-illness, com-
pared to the patients without any formal educations, those only 
with a secondary level of education had slightly higher income loss, 
likely because many of them were continuing with their education 
and were yet to enter into the job market.
In our analyses, we used agricultural labor as the reference for 
occupation. In reference to this group, non-agricultural labor, 
service holders or salaried job holders, the unemployed, stu-
dents, and housewives all had significant associations with the 
cost-of-illness. Throughout the three models, the coefficients for 
non- agricultural labor were positive and significantly different 
from zero (Supplementary Table 5), implying that those in non- 
agricultural labor incurred higher cost-of-illness than the agri-
cultural labor. Their loss of income was also higher. The service 
holders and the unemployed patients had positive associations 
only with the direct cost. In addition to receiving BRAC DOTS, 
the service holders had a fixed income and the unemployed 
patients depended on their family members for their treatment 
costs and these groups had greater opportunity to avail treat-
ments at private clinics. Additionally, the indirect cost of the 
unemployed were less by 2.15% as they hardly had any income. 
The cost-of-illness for students and housewives was also signifi-
cantly less. The income loss of the housewives is lower than that 
of the agricultural labors since their contributions in household 
works are not always monetized.
The cost-of-illness was positively related to the type of TB and the 
health-seeking behavior of the patients. The direct cost increased by 
28% for those with smear-negative TB. Interestingly, the direct cost 
of patients receiving medicines at home were higher likely because 
of their availing of other treatments. The interaction dummy with 
medicines given at home and taking other treatment is positive 
and significantly different from zero (Supplementary Table 5). This 
implies that the direct as well as the indirect costs were higher for 
those availing both private as well as cost-free services. Similarly, 
the cost-of-illness was higher for those receiving treatment prior 
to their enrollment in DOT and those who delayed their treatment 
after noticing the symptom of TB (Supplementary Table 5).
In Supplementary Table 5, models 4 and 6 represent the coefficients 
of a logistic regression model, and models 5 and 6 represent the 
corresponding OR for models 4 and 6, respectively. The outcome 
variable for model 4 is the incidence of CHE as defined by cost-
of-illness ≥10% of consumption expenditure; and for model 6 the 
outcome variable is CHE defined as cost-of-illness ≥40% of the 
non-food expenditure. It can be observed from model 6 that sex of 
patient was an important factors influencing the CHE - males had 
relatively higher chance of CHE than the females, and was related 
to higher indirect costs for the males. Model 6 demonstrated that 
divorced and widows were more prone to CHE.
Both models 4 and 6 demonstrates that the type of TB and 
health-seeking behavior of patients are major contributors to the 
incidence of CHE. There is 85% greater chance of consumption 
expenditure-based CHE and 200% greater chance (for non-
food-based CHE) for smear-negative patients compared to the 
smear-positives. Provision of medicines at homes make both 
type of patients less likely to face CHE - the chances of reducing 
CHE incidence are 53% and 46% in consumption and non-food 
expenditure- based CHE, respectively. Thus, delay in enrolling into 
DOTS increases the chances of experiencing CHE.
4. DISCUSSION
This study was based on a household survey to assess the incidence 
of CHE of the households of TB patients enrolled in BRAC DOTS, 
covering two-third areas of Bangladesh. Our study using two dif-
ferent indicators of CHE, 10% of the total consumption and 40% 
of non-food expenditure, noted the average incidence of 4.3% and 
3.1%, respectively. The highest incidence of over 5% was noted 
among the poorest quintiles for both the thresholds. This was in 
agreement with the earlier studies that reported a greater likelihood 
of CHE among poorer households in terms of social opportunities 
and income [17,27,32–34].
Previous studies in Bangladesh, lacking TB-specific data, reported 
the incidences of CHE, based on the proportion of overall health 
cost, at 7.1%, 9%, and 14.2% [35,36]. Studies in other countries 
reported higher CHE: 44% in Nigeria, 18% in India, and 71% 
in Benin [27,32]. A lower rate (10%) was reported for CHE for 
TB in a study conducted among Indian tribal population. Poor 
knowledge about TB in the community, less effective DOTS pro-
gram, delay in diagnosis, and absence of informal caregiver were 
major drivers in those settings where high catastrophic costs are 
reported [27,32]. A more comprehensive and effective TB con-
trol program in Bangladesh could be the reason for our observed 
lower CHE [37].
We noted CHE to vary by sex, marital status and employment 
status of the patients enrolled in BRAC DOTS. In the logit model, 
we observed higher incidence of CHE among males and currently 
single TB patients. Higher CHE among divorced and widowed 
patients can be explained by their lesser social support. The inci-
dence was also higher among TB patients with delayed enrollment 
into the DOTS, and those with smear-negative TB Studies con-
ducted in contexts similar to Bangladesh reported gender, age, edu-
cation and place of residence as significant determinants of CHE, 
in addition to poverty [35,38–41].
In the absence of TB-specific data in Bangladesh, the earlier 
reported CHE from different countries provided us with an idea 
about possible CHE among Bangladeshi TB patients, and helped us 
make comparisons across different settings. In comparing results, 
it would be important to remember different approaches of esti-
mating CHE used by different studies.
We estimated the average total cost of TB illness at 124 US$ of 
which 68% was indirect expenses. We identified loss of income of 
the patients and caregivers as the largest drivers of cost-of- illness, 
and consultation fees, diagnostic cost and medicine to make a 
large share of the total costs. Russell et al. [42] reported the direct 
and indirect costs of TB in the resource-poor countries were cat-
astrophic for households that impose high and regressive cost 
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burdens on the families TB-related social stigma has been noted 
as potential cause of loss of income and economic stability of the 
family. This is likely to influence TB health-seeking behavior that 
needs to be considered in devising strategies for the eradication of 
TB in Bangladesh and elsewhere.
The findings of our study may help set a roadmap to ensure that 
no household is burdened by TB-related CHE by 2030. Given the 
high incidence of CHE among the poor and vulnerable popula-
tions special intervention would be required to reduce or com-
pensate for the cost-of-illness of TB. The NTP can play a pivotal 
role in discussing this issue and in shaping the strategy. This study 
identified the high cost of TB illness are contributed by its diag-
nostics, medicine, food and travel cost, and loss of income and 
that the costs are higher for sputum-negative patients. Thus, the 
complete package of treatment should have provision for partial 
or full reimbursement all sorts of treatment costs including diag-
nostics of TB and medicine cost with compensation of income 
loss, depending on the income level of the patients’ families. In 
the absence of such provisions, TB patients and their families will 
continue to suffer from high CHE that is likely to result in reduced 
food consumption, more children out of school, and even selling 
of household assets to become more poor and vulnerable fueling 
the vicious cycle of poverty [43].
4.1. Strength and Limitation
This study follows the WHO recommended survey design tech-
niques and data collection tools that enhanced the reliability of 
its findings. The sample size was large enough to run statistical 
models and to get precise estimates. This study used simulation 
of the findings with Bayesian and regular simulation techniques 
that made the results more acceptable by different policymaking 
bodies.
All the information related to annual household income and 
expenditure, spending on food and health care were self- 
reported with possible recall bias. We, however, made efforts 
to minimize the recall bias by categorizing daily expenditures 
(for example rice, vegetables, etc.) and collecting such data on 
a weekly basis. Monthly food expenditure and other bills and 
fees (outsourcing, tobacco, betel leaf, school fees, amenity 
bills, etc.) were collected with monthly, and yearly expendi-
tures (clothes, festivals, furniture gazettes, etc.) collected with 
annual reference time. The study participants were only lim-
ited to BRAC managed DOTS centers but the fact remained 
that it represented two-third of the country’s population under 
DOTS intervention. TB patients enrolled in other partner 
NGO management or sought care from other sources or might 
be exposed to different levels of CHE. It should also be noted 
that this study did not accommodate for those who left the 
treatment with perceived or real financial and non-financial 
barriers that might have resulted in an underestimation of the 
incidence of household CHE. The MDR patients were purpose-
fully excluded from our study, to avoid greater complexity in 
collecting data, but it is conceivable that their inclusion would 
have provided a higher incidence of CHE. Like some others, 
ours was a cross- sectional survey and consequently lacked data 
required for a robust causal effect of impoverishment of the dis-
ease [32,44,45].
5. CONCLUSION
Despite free TB care, our study patients incurred considerable 
amount of cost-of-illness, both in direct and indirect (income loss) 
costs. The cost-of-illness of TB was largely contributed by income 
loss of the patients and their caregivers. The direct costs varied by 
their SES. The direct costs of the patients led to the incidence of 
CHE for many households. Though indirect costs do not influence 
the CHE incidences, special attention should be given to reduce 
the indirect cost incurred by TB patients and caregivers, which 
made up the largest share of the total cost-of-illness per patient. 
To comply with the “WHO’s End TB Strategy” of eliminating TB 
related CHE by 2030, it is important to make special provision 
for smear-negative TB patients and address the issue of delay in 
enrolment in DOTS. Special attention is necessary for the poorer 
segments of the population and other specific vulnerable groups, 
as noted in this study. Strategy needs to be developed for improv-
ing health-seeking behavior of people as well as home delivery of 
medicine that are likely to reduce the rates of CHE among the TB 
patients.
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